Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

rowex ltd - fluoxetine hydrochloride - capsule, hard - 20 milligram(s) - selective serotonin reuptake inhibitors; fluoxetine

Euroopa Liit - islandi - EMA (European Medicines Agency)

roche registration gmbh - baloxavir marboxil - inflúensu, manna - veirueyðandi lyf til almennrar notkunar - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

Euroopa Liit - norra - EMA (European Medicines Agency)

roche registration gmbh - baloxavir marboxil - influensa, human - antivirale midler til systemisk bruk - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

Serbia - serbia - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

hemofarm ad vrŠac - baloksavir marboksil -

Serbia - serbia - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

hemofarm ad vrŠac - baloksavir marboksil -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

a-s medication solutions - baloxavir marboxil (unii: 505cxm6ohg) (baloxavir - unii:4g86y4jt3f) - xofluza is indicated for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are: - otherwise healthy, or - at high risk of developing influenza-related complications1  [see clinical studies (14.2)]. xofluza is indicated for post-exposure prophylaxis of influenza in persons 12 years of age and older following contact with an individual who has influenza [see clinical studies (14.3)]. influenza viruses change over time, and factors such as the virus type or subtype, emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs. consider available information on drug susceptibility patterns for circulating influenza virus strains when deciding whether to use xofluza [see microbiology (12.4) and clinical studies (14)] . xofluza is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. serious allergic reactions have

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

a-s medication solutions - baloxavir marboxil (unii: 505cxm6ohg) (baloxavir - unii:4g86y4jt3f) - xofluza is indicated for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are: - otherwise healthy, or - at high risk of developing influenza-related complications1  [see clinical studies (14.2)]. xofluza is indicated for post-exposure prophylaxis of influenza in persons 12 years of age and older following contact with an individual who has influenza [see clinical studies (14.3)]. influenza viruses change over time, and factors such as the virus type or subtype, emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs. consider available information on drug susceptibility patterns for circulating influenza virus strains when deciding whether to use xofluza [see microbiology (12.4) and clinical studies (14)] . xofluza is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. serious allergic reactions have

Malaisia - inglise - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - baloxavir marboxil -

Malaisia - inglise - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - baloxavir marboxil -

Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

euro lifecare ltd - fluconazolum - comprimate - 200 mg